Cleared Traditional

K220337 - GaiaBone Bioabsorbable Bone Graft (FDA 510(k) Clearance)

Feb 2023
Decision
361d
Days
Class 2
Risk

K220337 is an FDA 510(k) clearance for the GaiaBone Bioabsorbable Bone Graft. This device is classified as a Filler, Bone Void, Calcium Compound (Class II - Special Controls, product code MQV).

Submitted by Corliber (Shenzhen) Medical Device Co., Ltd. (Shenzhen City, CN). The FDA issued a Cleared decision on February 3, 2023, 361 days after receiving the submission on February 7, 2022.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3045.

Submission Details

510(k) Number K220337 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 07, 2022
Decision Date February 03, 2023
Days to Decision 361 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code MQV - Filler, Bone Void, Calcium Compound
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3045